GlassScriptPhysician profile
Jinseo Choi
NPI 1386302479
$3,595.84
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,583 · 2023: $1,765 · 2024: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,012.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $658.20 | 2022-2024 | Relistor |
| Abbvie INC. | $450.30 | 2022-2024 | |
| Boston Scientific Corporation | $404.96 | 2022-2024 | Superion Indirect Decompression System |
| Biohaven Pharmaceutical Holding Company LTD. | $387.68 | 2022 | |
| Collegium Pharmaceutical, INC. | $271.21 | 2023-2024 | Belbuca, Xtampza |
| Medtronic, INC. | $258.11 | 2023-2024 | Intellis Adaptivestim, Accurian, Vanta Adaptivestim |
| Zynex Medical, INC. | $236.22 | 2023 | Nexwave |
| Almatica Pharma LLC | $232.54 | 2022-2023 | Gralise |
| Scilex Pharmaceuticals INC. | $187.58 | 2022-2024 | Ztlido |
| Pfizer INC. | $178.33 | 2023 | |
| Valinor Pharma, LLC | $65.25 | 2023-2024 | Movantik |
| Nalu Medical, INC. | $59.74 | 2022 | |
| Fidia Pharma USA INC. | $59.19 | 2022 | |
| Redhill Biopharma INC. | $31.44 | 2022 | |
| Nevro Corp. | $31.24 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $26.17 | 2022-2023 | Sprint Pns System |
| Corium, LLC | $22.04 | 2023 | Azstarys |
| Virtus Pharmaceuticals LLC | $20.17 | 2023 | Levorphanol Tartrate |
| Amneal Pharmaceuticals LLC | $15.47 | 2023 | Lyvispah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinseo Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.